Search
Close this search box.
Search
Close this search box.

Cyprus to Launch Microbial Resistance Platform in Early 2026

Nicosia: Cyprus is set to launch a platform for microbial resistance in early 2026, authorities announced on Thursday during a press conference, in Nicosia. The platform aims to contribute to the systematic surveillance of hospital-acquired infections, antimicrobial consumption, and antimicrobial resistance. This initiative is part of the National Action Plan for the Prevention and Control of Infections in the health sector and the National Strategy for Combating Antimicrobial Resistance.

According to Cyprus News Agency, the main parameters of the Action Plan and the Strategy were unveiled during the press conference at the Health Ministry, highlighting that Cyprus is among the EU member states with the highest use of antibiotics. Dr. Michalis Mendris, who presented the National Strategy for Combating Antimicrobial Resistance, stated that 1.27 million deaths worldwide are attributed to antimicrobial resistance, with another 4.95 million deaths associated with it, based on data from 2019.

Regarding Cyprus, figures indicate an increasing trend in both antibiotic use and antimicrobial resistance. Dr. Mendris emphasized the importance of recording and processing these figures, with the platform set to assist in this effort. Instructions were given to hospitals to establish antibiotic logistics teams, and cooperation is being developed with the Health Insurance Organisation (HIO) to monitor the prescription of medicines through the GeSY platform.

Dr. Despo Constantinou, presenting the National Action Plan for the prevention and control of infections, referenced figures from the European Center for Infection Prevention and Control. These figures show that approximately 20% of hospital infections, affecting 4.3 million patients in Europe annually, can be prevented through prevention and control programs.

Health Minister Neophytos Charalambides highlighted the tools developed to reduce hospital infections, strengthen surveillance, ensure the rational use of antimicrobials, and provide holistic treatment of antimicrobial resistance through sectoral cooperation. He mentioned that the establishment and operation of Local Infection Control Committees and Antibiotic Logistics teams in all hospitals, alongside mandatory submission of data through the platform, are integral components.

Deputy Permanent Secretary of the Health Ministry, Elisavet Constantinou, explained that these tools represent a scientifically documented effort to address infections, emphasizing the need for cooperation, consistency, and commitment from all stakeholders involved. Dr. Markella Markou described these tools as a milestone for the healthcare system in Cyprus, expecting all hospitals, including the eight public and approximately 75 private ones, to register on the platform by January 2026 to begin providing data.

Dr. Markou added that a manual was prepared by the KIOS Center of Excellence, which developed the electronic platform in collaboration with the Medical Services, funded by the EU Recovery and Resilience Fund. She acknowledged expected difficulties but noted the significant benefits that will contribute to addressing public health challenges.